Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Socio-environmental exposures and health outcomes among persons with sickle cell disease.

Asnani MR, Knight Madden J, Reid M, Greene LG, Lyew-Ayee P.

PLoS One. 2017 Apr 6;12(4):e0175260. doi: 10.1371/journal.pone.0175260. eCollection 2017.

2.

Voluntary premarital screening to prevent sickle cell disease in Jamaica: does it work?

Serjeant GR, Serjeant BE, Mason KP, Gibson F, Gardner R, Warren L, Jonker M.

J Community Genet. 2017 Apr;8(2):133-139. doi: 10.1007/s12687-017-0294-8. Epub 2017 Mar 1.

3.

Pulmonary vascular and ventricular dysfunction in the susceptible patient (2015 Grover Conference series).

Maron BA, Machado RF, Shimoda L.

Pulm Circ. 2016 Dec;6(4):426-438. doi: 10.1086/688315. Review.

4.

Nonhematopoietic Nrf2 dominantly impedes adult progression of sickle cell anemia in mice.

Ghosh S, Ihunnah CA, Hazra R, Walker AL, Hansen JM, Archer DR, Owusu-Ansah AT, Ofori-Acquah SF.

JCI Insight. 2016;1(4). pii: e81090. Epub 2016 Apr 7.

5.

Minireview: Clinical severity in sickle cell disease: the challenges of definition and prognostication.

Quinn CT.

Exp Biol Med (Maywood). 2016 Apr;241(7):679-88. doi: 10.1177/1535370216640385. Epub 2016 Mar 23. Review.

6.

Defining Sickle Cell Disease Mortality Using a Population-Based Surveillance System, 2004 through 2008.

Paulukonis ST, Eckman JR, Snyder AB, Hagar W, Feuchtbaum LB, Zhou M, Grant AM, Hulihan MM.

Public Health Rep. 2016 Mar-Apr;131(2):367-75.

7.

Prevention of sickle cell disease: observations on females with the sickle cell trait from the Manchester project, Jamaica.

Mason K, Gibson F, Gardner RA, Serjeant B, Serjeant GR.

J Community Genet. 2016 Apr;7(2):127-32. doi: 10.1007/s12687-015-0258-9. Epub 2015 Dec 2.

8.

Frequency distribution of sickle cell anemia, sickle cell trait and sickle/beta-thalassemia among anemic patients in Saudi Arabia.

Elsayid M, Al-Shehri MJ, Alkulaibi YA, Alanazi A, Qureshi S.

J Nat Sci Biol Med. 2015 Aug;6(Suppl 1):S85-8. doi: 10.4103/0976-9668.166093.

9.

The lived experiences of adolescents with sickle cell disease in Kingston, Jamaica.

Forrester AB, Barton-Gooden A, Pitter C, Lindo JL.

Int J Qual Stud Health Well-being. 2015 Sep 3;10:28104. doi: 10.3402/qhw.v10.28104. eCollection 2015.

10.

Prevention of Morbidity in sickle cell disease--qualitative outcomes, pain and quality of life in a randomised cross-over pilot trial of overnight supplementary oxygen and auto-adjusting continuous positive airways pressure (POMS2a): study protocol for a randomised controlled trial.

Howard J, Inusa B, Liossi C, Jacob E, Murphy PB, Hart N, Gavlak J, Sahota S, Chorozoglou M, Nwosu C, Gwam M, Gupta A, Rees DC, Thein SL, Reading IC, Kirkham FJ, Cheng MY.

Trials. 2015 Aug 25;16:376. doi: 10.1186/s13063-015-0883-y.

11.

A biopsychosocial model for the management of patients with sickle-cell disease transitioning to adult medical care.

Crosby LE, Quinn CT, Kalinyak KA.

Adv Ther. 2015 Apr;32(4):293-305. doi: 10.1007/s12325-015-0197-1. Epub 2015 Apr 2. Review.

12.

Survival and mortality among users and non-users of hydroxyurea with sickle cell disease.

de Araujo OM, Ivo ML, Ferreira Júnior MA, Pontes ER, Bispo IM, de Oliveira EC.

Rev Lat Am Enfermagem. 2015 Jan-Feb;23(1):67-73. doi: 10.1590/0104-1169.3385.2526. English, Portuguese, Spanish.

13.

Management of sickle cell disease: a review for physician education in Nigeria (sub-saharan Africa).

Adewoyin AS.

Anemia. 2015;2015:791498. doi: 10.1155/2015/791498. Epub 2015 Jan 18. Review.

14.

Trends in mortality and hospital admissions of sickle cell disease patients before and after the newborn screening program in Maranhão, Brazil.

Lima AR, Ribeiro VS, Nicolau DI.

Rev Bras Hematol Hemoter. 2015 Jan-Feb;37(1):12-6. doi: 10.1016/j.bjhh.2014.11.009. Epub 2014 Nov 21.

15.

Remembering the forgotten non-communicable diseases.

Lopez AD, Williams TN, Levin A, Tonelli M, Singh JA, Burney PG, Rehm J, Volkow ND, Koob G, Ferri CP.

BMC Med. 2014 Oct 22;12:200. doi: 10.1186/s12916-014-0200-8.

16.

Sickle cell disease: a neglected chronic disease of increasing global health importance.

Chakravorty S, Williams TN.

Arch Dis Child. 2015 Jan;100(1):48-53. doi: 10.1136/archdischild-2013-303773. Epub 2014 Sep 19. Review.

17.

Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.

Hsieh MM, Fitzhugh CD, Weitzel RP, Link ME, Coles WA, Zhao X, Rodgers GP, Powell JD, Tisdale JF.

JAMA. 2014 Jul 2;312(1):48-56. doi: 10.1001/jama.2014.7192.

18.

Cost-effectiveness analysis of preoperative transfusion in patients with sickle cell disease using evidence from the TAPS trial.

Spackman E, Sculpher M, Howard J, Malfroy M, Llewelyn C, Choo L, Hodge R, Johnson T, Rees DC, Fijnvandraat K, Kirby-Allen M, Davies S, Williamson L.

Eur J Haematol. 2014 Mar;92(3):249-55. doi: 10.1111/ejh.12232. Epub 2013 Dec 12.

19.

The natural history of sickle cell disease.

Serjeant GR.

Cold Spring Harb Perspect Med. 2013 Oct 1;3(10):a011783. doi: 10.1101/cshperspect.a011783. Review.

20.

Sickle cell disease in pregnancy: trend and pregnancy outcomes at a tertiary hospital in Tanzania.

Muganyizi PS, Kidanto H.

PLoS One. 2013;8(2):e56541. doi: 10.1371/journal.pone.0056541. Epub 2013 Feb 13.

Supplemental Content

Support Center